Empagliflozin 10Mg Tab

DRUG2 trials

Sponsors

Assistance Publique Hopitaux De Marseille, Research Institute for Complex Problems of Cardiovascular Diseases, Russia

Conditions

Coronary Artery DiseaseDiabetes MellitusPercutaneous Coronary InterventionType 2 Diabetes

Phase 3

Impact of Empaglifozine on Cardiac Ectopic Fat

CompletedNCT03118336

Assistance Publique Hopitaux De MarseilleType 2 Diabetes

Start: 2017-06-16End: 2020-02-07Updated: 2020-02-17

Phase 4

Safety and Efficacy of Empagliflozin for Patients With Diabetes Mellitus and Planned Percutaneous Coronary Interventions

CompletedNCT04497792

Research Institute for Complex Problems of Cardiovascular Diseases, RussiaCoronary Artery Disease, Diabetes Mellitus, Percutaneous Coronary Intervention

Start: 2016-11-30End: 2019-11-30Updated: 2021-09-22

Related Papers

Effect of empagliflozin on ectopic fat stores and myocardial energetics in type 2 diabetes: the EMPACEF study.

2021-03-01112 citations